Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen

Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer Inc and AstraZeneca Plc are combined in a two-shot schedule.